PROTOCOL SUMMARY FOR PATIENTS

View Professional Summary

Study of Regorafenib After Sorafenib in Patients With Hepatocellular Carcinoma

Study of Regorafenib After Sorafenib in Patients With Hepatocellular Carcinoma


Basic Trial Information

Protocol Phase:Phase III
Study Category:Treatment
Current Protocol StatusActive
Age18 and over
Protocol SponsorPharmaceutical/Industry
Primary ID15982
Other IDNCT01774344
Special Category

TRIAL DESCRIPTION

Purpose:
Eligibility:
Treatment Intervention:
Patient Disclaimer: